drugset / Trial / NCT05608447

Effect of Intensive FMT on Primary Hypertension

NCT05608447 ↗

RandomizedParallel-groupDouble-blindTreatment

Summary

Mounting preclinical and clinical evidences have proved the causal role of gut microbiota on the pathogenesis of primary hypertension. Restoration of gut microbiota ameliorated high BP in rodents and/or human cases.A hypothesis is thus raised that gut microbiome restoration can be a potential approach to ameliorate hypertension. This study will perform intense fecal microbiota transplantation (FMT) intervention via oral capsules, in comparison with placebo capsules, to investigate the effect, safety and underlying mechanisms of gut microbiome intervention on primary hypertension.

Timeline

Start
2023-01-01
Primary completion
2023-06-01
Completion
2023-09-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator fecal microbiota transplantation Unknown — Oral